Free Trial

Northern Trust Corp Acquires 296,911 Shares of Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Northern Trust Corp grew its position in shares of Genpact Limited (NYSE:G - Free Report) by 27.0% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,395,029 shares of the business services provider's stock after buying an additional 296,911 shares during the quarter. Northern Trust Corp owned 0.79% of Genpact worth $59,916,000 as of its most recent filing with the SEC.

Other large investors have also modified their holdings of the company. Blue Trust Inc. increased its holdings in Genpact by 8.7% during the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after purchasing an additional 441 shares during the last quarter. Burney Co. grew its holdings in Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after acquiring an additional 92,641 shares in the last quarter. KBC Group NV acquired a new stake in shares of Genpact in the 4th quarter valued at about $298,000. State of New Jersey Common Pension Fund D bought a new position in shares of Genpact during the fourth quarter worth about $2,030,000. Finally, Pictet Asset Management Holding SA acquired a new position in Genpact in the fourth quarter worth about $921,000. 96.03% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the sale, the chief executive officer now directly owns 310,246 shares of the company's stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 3.07% of the stock is currently owned by company insiders.

Genpact Stock Performance

Shares of NYSE:G traded up $0.41 on Friday, reaching $42.45. 3,113,784 shares of the company's stock were exchanged, compared to its average volume of 1,363,096. The company has a fifty day moving average of $48.93 and a 200-day moving average of $46.92. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $7.46 billion, a price-to-earnings ratio of 14.95, a PEG ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The firm had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. Genpact had a net margin of 10.77% and a return on equity of 22.50%. The business's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.73 earnings per share. On average, research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Jefferies Financial Group raised Genpact from a "hold" rating to a "buy" rating and raised their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Mizuho lifted their price objective on shares of Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Needham & Company LLC reduced their price target on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research report on Thursday. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and boosted their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Robert W. Baird cut their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday. Five analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, Genpact currently has a consensus rating of "Hold" and an average target price of $48.75.

Read Our Latest Stock Report on Genpact

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines